Market Cap 412.64M
Revenue (ttm) 5.82M
Net Income (ttm) 71.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,223.02%
Debt to Equity Ratio 0.12
Volume 1,178,700
Avg Vol 1,239,018
Day's Range N/A - N/A
Shares Out 57.00M
Stochastic %K 99%
Beta 1.35
Analysts Strong Sell
Price Target $19.71

Company Profile

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 813 4701
Address:
6555 Carnegie Avenue, 4th Floor, Cleveland, United States
Idontknownothing55
Idontknownothing55 Aug. 11 at 7:52 AM
$ABEO it's time for lift off!!!!!!
0 · Reply
alexpitti
alexpitti Aug. 10 at 10:30 PM
it makes no sense for $ABEO to have hitting breakeven in july in their presentation when july is over. the point is they need 3 treatments per month. and nothing changed in their guidance
0 · Reply
Zweagel91
Zweagel91 Aug. 10 at 8:22 PM
$ABEO as the earnings increase, this thing will follow like a rocket. People will wish in 3/6 months they got in below $10. If june was the first month in black a re-rating/short squeeze is definitely possible. All this manipulation unraveling as we speak! Still 36% short interest...
0 · Reply
tmoney4572
tmoney4572 Aug. 10 at 8:10 PM
$ABEO yep
1 · Reply
tmoney4572
tmoney4572 Aug. 10 at 8:02 PM
$ABEO the time is now longs, we ride though earnings but I’m confident tomorrow will be a -1%-3% day. So don’t get shook out
1 · Reply
tmoney4572
tmoney4572 Aug. 10 at 7:29 PM
0 · Reply
QuantumHarbor
QuantumHarbor Aug. 10 at 3:30 PM
$RNG $ABEO $FIG $LULU $PSNL RingCentral benefits from cloud communications demand, Abeona advances cell and gene therapies, FIG remains execution-dependent, Lululemon remains focused on premium apparel growth, and PSNL remains speculative. I'm watching recurring revenue, clinical milestones, consumer demand, and liquidity.
0 · Reply
Idontknownothing55
Idontknownothing55 Aug. 10 at 3:05 PM
$ABEO Popeye is waking up. ABEO is a keeper don't let her go easily.
0 · Reply
TragicRain
TragicRain Aug. 10 at 2:41 PM
$ABEO - Remember the science here. This is a commercial driven business now in its first year, with a life saving product. That is insane, and so many of us have gotten in at insane CB. Long term hold, goal is 10k shares - buying under $6, because I dont think we will see under $5 again.
0 · Reply
PPT_for_me
PPT_for_me Aug. 10 at 1:57 PM
$ABEO Dump it, this is classic micro cap biotech, these guys are good scientists but crap business people, they don't know how to bring this thing to market and run a distribution company. Hopefully they get bought out at some point by people that know what they're doing.
1 · Reply
Latest News on ABEO
Abeona Therapeutics Transcript: AGM 2026

Jun 12, 2026, 9:00 AM EDT - 2 months ago

Abeona Therapeutics Transcript: AGM 2026


Abeona Therapeutics Slides: Investor presentation

Jun 10, 2026, 7:00 AM EDT - 2 months ago

Abeona Therapeutics Slides: Investor presentation


Abeona Therapeutics Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Abeona Therapeutics Earnings Call Transcript: Q1 2026


Abeona Therapeutics Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Abeona Therapeutics Earnings release: Q1 2026


Abeona Therapeutics Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Abeona Therapeutics Quarterly report: Q1 2026


Abeona Therapeutics Slides: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Abeona Therapeutics Slides: Q1 2026


Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)

2026-05-13T12:17:05.000Z - 3 months ago

Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)


Abeona Therapeutics Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 3 months ago

Abeona Therapeutics Proxy statement: Proxy filing


Abeona Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Abeona Therapeutics Proxy statement: Proxy filing


Abeona Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Abeona Therapeutics Proxy statement: Proxy filing


Abeona Therapeutics Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 4 months ago

Abeona Therapeutics Slides: Corporate presentation


Abeona Therapeutics Earnings Call Transcript: Q4 2025

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Abeona Therapeutics Earnings Call Transcript: Q4 2025


Abeona Therapeutics Annual report: Q4 2025

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Abeona Therapeutics Annual report: Q4 2025


Abeona Therapeutics Earnings release: Q4 2025

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Abeona Therapeutics Earnings release: Q4 2025


Abeona Therapeutics announces employee inducement grants

2025-12-31T12:35:26.000Z - 7 months ago

Abeona Therapeutics announces employee inducement grants


Abeona Therapeutics appoints Mohamad Tabrizi as CBO

2025-12-15T12:36:04.000Z - 8 months ago

Abeona Therapeutics appoints Mohamad Tabrizi as CBO


Abeona Therapeutics reports employee inducement grants

2025-12-01T12:35:41.000Z - 9 months ago

Abeona Therapeutics reports employee inducement grants


Abeona Therapeutics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

Abeona Therapeutics Earnings Call Transcript: Q3 2025


Abeona Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

Abeona Therapeutics Quarterly report: Q3 2025


Abeona Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

Abeona Therapeutics Earnings release: Q3 2025


Abeona Therapeutics reports Q3 EPS (10c), consensus (34c)

2025-11-12T12:36:04.000Z - 9 months ago

Abeona Therapeutics reports Q3 EPS (10c), consensus (34c)


Abeona Therapeutics sees cash runway for over two years

2025-11-12T12:35:51.000Z - 9 months ago

Abeona Therapeutics sees cash runway for over two years


Abeona Therapeutics announces employee inducement grants

2025-11-03T12:35:07.000Z - 10 months ago

Abeona Therapeutics announces employee inducement grants


Abeona Therapeutics announces permanent J-Code for ZEVASKYN

2025-10-30T14:50:28.000Z - 10 months ago

Abeona Therapeutics announces permanent J-Code for ZEVASKYN


Abeona Therapeutics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q2 2025


Abeona Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Earnings release: Q2 2025


Abeona Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Quarterly report: Q2 2025


Abeona Therapeutics Earnings Call Transcript: Q1 2025

May 15, 2025, 7:00 AM EDT - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q1 2025


Abeona Therapeutics Earnings release: Q1 2025

May 15, 2025, 7:00 AM EDT - 1 year ago

Abeona Therapeutics Earnings release: Q1 2025


Abeona Therapeutics Quarterly report: Q1 2025

May 15, 2025, 7:00 AM EDT - 1 year ago

Abeona Therapeutics Quarterly report: Q1 2025


US FDA approves Abeona's skin disorder therapy

Apr 29, 2025, 6:06 AM EDT - 1 year ago

US FDA approves Abeona's skin disorder therapy


Abeona Therapeutics Proxy statement: Proxy Filing

Apr 9, 2025, 8:00 AM EDT - 1 year ago

Abeona Therapeutics Proxy statement: Proxy Filing


Abeona Therapeutics Earnings Call Transcript: Q4 2024

Mar 20, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q4 2024


Abeona Therapeutics Earnings release: Q4 2024

Mar 20, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Earnings release: Q4 2024


Abeona Therapeutics Annual report: Q4 2024

Mar 20, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Annual report: Q4 2024


Abeona Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q3 2024


Abeona Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics Quarterly report: Q3 2024


Abeona Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics Earnings release: Q3 2024


Abeona Therapeutics Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Abeona Therapeutics Proxy statement: Proxy Filing


Abeona Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Abeona Therapeutics Earnings Call Transcript: Q2 2024


Abeona Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Abeona Therapeutics Quarterly report: Q2 2024


Abeona Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Abeona Therapeutics Earnings release: Q2 2024


Idontknownothing55
Idontknownothing55 Aug. 11 at 7:52 AM
$ABEO it's time for lift off!!!!!!
0 · Reply
alexpitti
alexpitti Aug. 10 at 10:30 PM
it makes no sense for $ABEO to have hitting breakeven in july in their presentation when july is over. the point is they need 3 treatments per month. and nothing changed in their guidance
0 · Reply
Zweagel91
Zweagel91 Aug. 10 at 8:22 PM
$ABEO as the earnings increase, this thing will follow like a rocket. People will wish in 3/6 months they got in below $10. If june was the first month in black a re-rating/short squeeze is definitely possible. All this manipulation unraveling as we speak! Still 36% short interest...
0 · Reply
tmoney4572
tmoney4572 Aug. 10 at 8:10 PM
$ABEO yep
1 · Reply
tmoney4572
tmoney4572 Aug. 10 at 8:02 PM
$ABEO the time is now longs, we ride though earnings but I’m confident tomorrow will be a -1%-3% day. So don’t get shook out
1 · Reply
tmoney4572
tmoney4572 Aug. 10 at 7:29 PM
0 · Reply
QuantumHarbor
QuantumHarbor Aug. 10 at 3:30 PM
$RNG $ABEO $FIG $LULU $PSNL RingCentral benefits from cloud communications demand, Abeona advances cell and gene therapies, FIG remains execution-dependent, Lululemon remains focused on premium apparel growth, and PSNL remains speculative. I'm watching recurring revenue, clinical milestones, consumer demand, and liquidity.
0 · Reply
Idontknownothing55
Idontknownothing55 Aug. 10 at 3:05 PM
$ABEO Popeye is waking up. ABEO is a keeper don't let her go easily.
0 · Reply
TragicRain
TragicRain Aug. 10 at 2:41 PM
$ABEO - Remember the science here. This is a commercial driven business now in its first year, with a life saving product. That is insane, and so many of us have gotten in at insane CB. Long term hold, goal is 10k shares - buying under $6, because I dont think we will see under $5 again.
0 · Reply
PPT_for_me
PPT_for_me Aug. 10 at 1:57 PM
$ABEO Dump it, this is classic micro cap biotech, these guys are good scientists but crap business people, they don't know how to bring this thing to market and run a distribution company. Hopefully they get bought out at some point by people that know what they're doing.
1 · Reply
tmoney4572
tmoney4572 Aug. 10 at 1:44 PM
$ABEO CAN I GET A $7.50?
1 · Reply
invest2021_now
invest2021_now Aug. 10 at 1:37 PM
0 · Reply
alexpitti
alexpitti Aug. 10 at 1:09 PM
people have no idea what a disaster is. or they are purposely spreading fear $ABEO
1 · Reply
Po556677
Po556677 Aug. 10 at 10:43 AM
$ABEO Here we are folks..earnings week!!!Would love to see this pull back a little then explode after earnings/we will see/future is bright
1 · Reply
alexpitti
alexpitti Aug. 9 at 8:49 PM
I think abeona can do $27.6 million in q3 sales vs q2 estimate of $20 million. if estimates get raised, the stock can spike. just think of doing 1.25 per month at the main 2 centers and then colorado does 2 treatments. my source says colorado will do the first treatment soon. that could be a nice situation to see a 3rd center can get up and running even if it's 1 month later than i wanted. source says texas has older patients entering its que. maybe they start treating patients in q4 and we exit 2026 with 4 ACTIVE active sites and 7 active (3 inactive) sites. $ABEO
3 · Reply
realtorstud
realtorstud Aug. 9 at 7:43 PM
$ABEO 8+ soon...we have not been over $8 in 5 years.
1 · Reply
acm20
acm20 Aug. 9 at 1:26 AM
$ABEO "Buy or Hold candidate since Jul 29, 2026 Gain 16.21% The Abeona Therapeutics Inc. stock price gained 4.93% on the last trading day (Friday, 7th Aug 2026), rising from $6.90 to $7.24. During the last trading day the stock fluctuated 5.19% from a day low at $6.94 to a day high of $7.30. The price has risen in 6 of the last 10 days and is up by 19.67% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 568 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $10.11 million. The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 24.15% during the next 3 months and, with a 90% probability hold a price between $7.71 and $9.56 at the end of this 3-month period."
0 · Reply
tmoney4572
tmoney4572 Aug. 7 at 9:46 PM
$ABEO we can go 2/2
2 · Reply
invest2021_now
invest2021_now Aug. 7 at 8:34 PM
$ABEO Good Day! Let's keep it going next week!
0 · Reply
tmoney4572
tmoney4572 Aug. 7 at 7:17 PM
$ABEO it’s gonna buss
0 · Reply
JimiJoJeeter
JimiJoJeeter Aug. 7 at 5:55 PM
$ABEO 👇😉🤣😂🤣
0 · Reply
alexpitti
alexpitti Aug. 7 at 5:00 PM
$ABEO don't get excited, they report in 3 business days and the stock can fall right back down
1 · Reply